Adam J. Gormley

Adam Gormley is an Associate Professor of Biomedical Engineering at Rutgers University, Executive Editor of Advanced Drug Delivery Reviews, and co-founder of Plexymer, Inc. Prior to Rutgers, Adam was a Marie Skłodowska-Curie Research Fellow at the Karolinska Institutet (2016) and a Whitaker International Scholar at Imperial College London (2012-2015) in the laboratory of Professor Molly Stevens. He obtained his PhD in Bioengineering from the University of Utah in the laboratory of Professor Hamid Ghandehari (2012), and a BS in Mechanical Engineering from Lehigh University (2006). In January 2017, Adam started the Gormley Lab which seeks to develop bioactive nanobiomaterials using robotics and artificial intelligence. Dr. Gormley is currently the PI of a OVPR ML/AI Pilot Seed Grant as well as an NIH R35 MIRA Award, an NSF CBET Award, and an NSF Designing Materials to Revolutionize and Engineer our Future (DMREF) Award. He is the recipient of the A. Walter Tyson Assistant Professorship, the Young Innovator Award by Cellular and Molecular Bioengineering, and the Presidential Fellowship for Teaching Excellence.